Affinity Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Buy |
23,780
+2,272
| +11% | +$175K | 1.07% | 32 |
|
|
2025
Q4 | $1.71M | Sell |
21,508
-108
| -0.5% | -$8.51K | 1.13% | 27 |
|
|
2025
Q3 | $1.63M | Buy |
21,616
+2,422
| +13% | +$166K | 1.1% | 30 |
|
|
2025
Q2 | $1.32M | Buy |
19,194
+11,062
| +136% | +$725K | 1% | 38 |
|
|
2025
Q1 | $551K | Sell |
8,132
-3,722
| -31% | -$223K | 0.45% | 80 |
|
|
2024
Q4 | $532K | Sell |
11,854
-4,816
| -29% | -$270K | 0.44% | 80 |
|
|
2024
Q3 | $1.05M | Sell |
16,670
-8,158
| -33% | -$476K | 0.72% | 52 |
|
|
2024
Q2 | $1.47M | Sell |
24,828
-2,597
| -9% | -$162K | 1.1% | 31 |
|
|
2024
Q1 | $2.19M | Buy |
27,425
+291
| +1% | +$22.2K | 1.6% | 16 |
|
|
2023
Q4 | $2.14M | Sell |
27,134
-1,177
| -4% | -$83.8K | 1.46% | 12 |
|
|
2023
Q3 | $1.98M | Sell |
28,311
-1,283
| -4% | -$90.9K | 1.28% | 14 |
|
|
2023
Q2 | $2.05M | Sell |
29,594
-3,124
| -10% | -$222K | 1.18% | 16 |
|
|
2023
Q1 | $2.43M | Sell |
32,718
-4,639
| -12% | -$389K | 1.3% | 13 |
|
|
2022
Q4 | $3.48M | Buy |
37,357
+165
| +0.4% | +$15.9K | 1.6% | 7 |
|
|
2022
Q3 | $3.55M | Sell |
37,192
-279
| -0.7% | -$27.6K | 1.84% | 6 |
|
|
2022
Q2 | $3.47M | Sell |
37,471
-912
| -2% | -$89K | 1.69% | 7 |
|
|
2022
Q1 | $3.88M | Sell |
38,383
-3,604
| -9% | -$379K | 1.59% | 6 |
|
|
2021
Q4 | $4.33M | Buy |
41,987
+3
| +0% | +$277 | 1.74% | 6 |
|
|
2021
Q3 | $3.56M | Buy |
41,984
+560
| +1% | +$46.9K | 1.6% | 7 |
|
|
2021
Q2 | $3.46M | Sell |
41,424
-19,065
| -32% | -$1.56M | 1.56% | 8 |
|
|
2021
Q1 | $4.55M | Sell |
60,489
-5,046
| -8% | -$368K | 1.67% | 13 |
|
|
2020
Q4 | $4.48M | Sell |
65,535
-2,347
| -3% | -$153K | 1.8% | 10 |
|
|
2020
Q3 | $3.96M | Buy |
67,882
+5,281
| +8% | +$329K | 1.74% | 15 |
|
|
2020
Q2 | $4.07M | Sell |
62,601
-13,419
| -18% | -$845K | 1.93% | 10 |
|
|
2020
Q1 | $4.51M | Buy |
76,020
+2,636
| +4% | +$176K | 2.3% | 10 |
|
|
2019
Q4 | $5.45M | Sell |
73,384
-24,518
| -25% | -$1.72M | 1.98% | 11 |
|
|
2019
Q3 | $6.17M | Sell |
97,902
-12,657
| -11% | -$750K | 1.94% | 12 |
|
|
2019
Q2 | $6.02M | Sell |
110,559
-48,610
| -31% | -$2.62M | 1.73% | 15 |
|
|
2019
Q1 | $8.58M | Sell |
159,169
-18,901
| -11% | -$1.17M | 1.76% | 18 |
|
|
2018
Q4 | $11.7M | Buy |
+178,070
| New | +$13.3M | 2.04% | 14 |
|
|
2017
Q1 | – | Sell |
-2,775
| Closed | -$219K | – | 190 |
|
|
2016
Q4 | $219K | Hold |
2,775
| – | – | 0.02% | 148 |
|
|
2016
Q3 | $247K | Buy |
2,775
+20
| +0.7% | +$1.89K | 0.02% | 141 |
|
|
2016
Q2 | $264K | Hold |
2,755
| – | – | 0.02% | 142 |
|
|
2016
Q1 | $286K | Sell |
2,755
-290
| -10% | -$28.2K | 0.03% | 131 |
|
|
2015
Q4 | $298K | Sell |
3,045
-90
| -3% | -$8.81K | 0.03% | 131 |
|
|
2015
Q3 | $302K | Buy |
3,135
+606
| +24% | +$63.7K | 0.03% | 131 |
|
|
2015
Q2 | $265K | Buy |
+2,529
| New | +$258K | 0.02% | 127 |
|
Other funds holding CVS
VCM
VPM
Affinity Investment Advisors's CVS Position: Q1 2026 in Review
Affinity Investment Advisors increased its CVS Health (CVS) stake by 11% in Q1 2026, buying an estimated $175K and bringing the position to 23,780 shares worth $1.71M. The position accounts for 1.07% of the portfolio, ranked #32.
Affinity Investment Advisors first reported a position in CVS in Q2 2015 and has held it in 37 quarters since. The position peaked at $11.7M in Q4 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Affinity Investment Advisors held 23,780 shares of CVS Health worth $1.71M as of Q1 2026.
- Affinity Investment Advisors bought 2,272 CVS Health shares in Q1 2026, an estimated $175K.
- CVS Health made up 1.07% of Affinity Investment Advisors's portfolio in Q1 2026, its #32 holding.
- Affinity Investment Advisors first reported a position in CVS Health in Q2 2015 and has held it in 37 quarters since.
- Affinity Investment Advisors's CVS Health position peaked at $11.7M in Q4 2018.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Affinity Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.